SLC25A30 antisense RNA 1 (SLC25A30-AS1)

SLC25A30 antisense RNA 1 (SLC25A30-AS1) is a long non-coding RNA (lncRNA) that is transcribed as a natural antisense transcript (NAT) from the region opposite to the SLC25A30 gene on chromosome 13[1][5][3]. Like other lncRNAs, SLC25A30-AS1 is not thought to encode a protein, and its specific molecular or cellular functions remain uncharacterized in public genomic and functional resources[5][1]. While other antisense RNAs have been implicated in cancer biology and gene regulation, there are currently no published studies directly describing the biological function, disease relevance, or therapeutic targeting of SLC25A30-AS1 itself[1][5][3]. There are no known drugs, clinical biomarkers, or mechanism-of-action data linked to this molecule. SLC25A30-AS1 should not be confused with the functionally characterized SLC25A30 gene, which encodes a mitochondrial transporter protein[7]. Note: The information above is distinct from studies on related lncRNAs (like SLC25A25-AS1, which has been studied in cancer)[2]; no such data currently exists for SLC25A30-AS1 itself. Evidence and details: - Gene locus: Human chromosome 13 (Chr13:45418162-45420371, GRCh38)[1][5] - Transcript info: NR_047031.1, CA311633.1 are transcript accessions for SLC25A30-AS1[1] - Molecular family: Classified as a long non-coding RNA and natural antisense transcript[6] - No known protein product, functions, or drug interactions reported in major databases or the literature as of this date[5][1][3] If highly specific targeting or clinical implications are required, consider the absence of current functional or therapeutic evidence for this molecule.